Experts said broader physician uptake, improved availability, and relatively lower pricing versus competition are helping semaglutide close the gap
Effects: By activating GLP-1 receptors, Tirzepatide increases insulin secretion in response to meals, reduces glucagon release (which helps lower blood sugar), and slows gastric emptying (promoting feelings of fullness)
Fasting glucose decreased significantly at all dose levels above 1mg
Even after quitting GLP-1 treatments, however, youre still getting at least some benefit [with at least 5 percent weight loss], which is great, says Chika Anekwe, an obesity medicine physician at Massachusetts General Hospital Weight Center, but not the entire benefit that you would if you could keep off the majority of the weight. Other studies paint a similar picture
This means they bond with naturally-occurring chemical receptors in your body, activating them
This increases native GLP-1 levels in your bloodstream